Correlation Between Adaptive Biotechnologies and Reneo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Adaptive Biotechnologies and Reneo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptive Biotechnologies and Reneo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adaptive Biotechnologies Corp and Reneo Pharmaceuticals, you can compare the effects of market volatilities on Adaptive Biotechnologies and Reneo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptive Biotechnologies with a short position of Reneo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptive Biotechnologies and Reneo Pharmaceuticals.

Diversification Opportunities for Adaptive Biotechnologies and Reneo Pharmaceuticals

0.38

Correlation Coefficient

Adaptive Biotechnologies  Reneo Pharmaceuticals

Weak diversification

The 3 months correlation between Adaptive and Reneo is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Adaptive Biotechnologies Corp and Reneo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reneo Pharmaceuticals and Adaptive Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptive Biotechnologies Corp are associated (or correlated) with Reneo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reneo Pharmaceuticals has no effect on the direction of Adaptive Biotechnologies i.e., Adaptive Biotechnologies and Reneo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Adaptive Biotechnologies and Reneo Pharmaceuticals

Given the investment horizon of 90 days Adaptive Biotechnologies is expected to generate 2.73 times less return on investment than Reneo Pharmaceuticals. In addition to that, Adaptive Biotechnologies is 1.81 times more volatile than Reneo Pharmaceuticals. It trades about 0.11 of its total potential returns per unit of risk. Reneo Pharmaceuticals is currently generating about 0.53 per unit of volatility. If you would invest  1,620  in Reneo Pharmaceuticals on September 26, 2024 and sell it today you would earn a total of  200.00  from holding Reneo Pharmaceuticals or generate 12.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	12.7%
Values	Daily Returns

Adaptive Biotechnologies Corp  vs.  Reneo Pharmaceuticals

Adaptive Biotechnologies

Risk-Adjusted Performance

8 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Adaptive Biotechnologies Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Adaptive Biotechnologies unveiled solid returns over the last few months and may actually be approaching a breakup point.

Reneo Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Excellent

Over the last 90 days Reneo Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very unsteady technical indicators, Reneo Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Adaptive Biotechnologies and Reneo Pharmaceuticals

The main advantage of trading using opposite Adaptive Biotechnologies and Reneo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptive Biotechnologies position performs unexpectedly, Reneo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reneo Pharmaceuticals will offset losses from the drop in Reneo Pharmaceuticals' long position.

The idea behind Adaptive Biotechnologies Corp and Reneo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.